[Skip to Content]
[Skip to Content Landing]
Article
January 1960

Chlorothiazide and Electrolyte Depletion in Chronic Glomerulonephritis

Author Affiliations
Brooklyn
From the Anuria and Fluid Balance Unit, Department of Medicine, Jewish Hospital of Brooklyn and Downstate Medical Center, State University of New York.
AMA Arch Intern Med. 1960;105(1):7-12. doi:10.1001/archinte.1960.00270130023003
Abstract

Because of its diuretic and antihypertensive actions, chlorothiazide has been recommended for use in edematous and hypertensive states,1-10 including renal disease.11-13 Although chlorothiazide is known to cause increased excretion of Na and K,14-21 only few untoward clinical reactions have been described during its use.22-26 However, since patients with renal insufficiency may have a diminished ability to conserve Na, K, and Cl ions, the administration of such a diuretic might accentuate the process of depletion. We present two cases of chronic glomerulonephritis to emphasize the dangers in the use of chlorothiazide in patients with renal insufficiency. In each case electrolyte balance studies were carried out, including the measurement of total exchangeable Na and K by the isotope dilution principle.

Method  Serum and urine Na and K were determined by flame photometry. Osmolality of serum and urine was measured by the method of freezing point depression using the Fiske Osmometer. Na22 and K42

References
1.
Moyer, J. H.; Ford, R. V., and Spurr, C. L.:  Pharmacodynamics of Chlorothiazide (Diuril), an Orally Effective Non-Mercurial Diuretic Agent ,  Proc. Soc. Exper. Biol. & Med. 95:529-531, 1957.
2.
Freis, E. D.; Wanko, A.; Wilson, I. M., and Parrish, A. E.:  Treatment of Essential Hypertension with Chlorothiazide (Diuril) ,  J.A.M.A. 166:137-140, 1958.
3.
Davies, D. W., and Evans, B.:  Early Observations on the Diuretic Effect of Oral Chlorothiazide ,  Brit. M.J. 1:967-969, 1958.
4.
Assali, N. S.; Judd, L.; Mondz, N., and Dasgupta, K.:  Diuretic Effects of Chlorothiazide in Toxemia of Pregnancy ,  J. Lab. & Clin. Med. 52:423-435, 1958.
5.
Assali, N. S.; Judd, L., and Mondz, N.:  Clinical and Metabolic Study of Chlorothiazide (Diuril) ,  J.A.M.A. 169:26-29, 1959.
6.
Keyes, J. W., and Berlacher, F. J.:  Chlorothiazide (Diuril): A New Nonmercurial Orally Given Diuretic ,  J.A.M.A. 169:109-112, 1959.
7.
Jungck, E. C.; Barfield, W. C., and Greenblatt, R. B.:  Chlorothiazide and Premenstrual Tension ,  J.A.M.A. 169:112-114, 1959.
8.
Ford, R. V.; Moyer, J. H., and Spurr, C. L.:  Clinical and Laboratory Observations on Chlorothiazide (Diuril) ,  A.M.A. Arch. Int. Med. 100: 582-596, 1957.
9.
Finnerty, F. A., Jr.; Buchholz, J. H., and Tuckman, J.:  Evaluation of Chlorothiazide (Diuril) in the Toxemias of Pregnancy ,  J.A.M.A. 166:141-144, 1958.
10.
Goodkind, M. J.; Harvey, R. M., and Richards, D. W.:  Use of Chlorothiazide in the Treatment of Edema ,  Am. J.M. Sc. 235:164-167, 1958.
11.
Laragh, J. H., and Demartini, F. E.:  Chlorothiazide in the Management of Edema of Heart Failure, Nephrosis and Cirrhosis ,  Circulation 16: 904, 1957.
12.
Laragh, J. H.; Heinemann, H. O., and Demartini, F. E.:  Effect of Chlorothiazide on Electrolyte Transport in Man ,  J.A.M.A. 166:145-152, 1958.
13.
Watson, W. C.; Thomson, T. J., and Buchanan, J. M.:  Clinical and Laboratory Studies with Chlorothiazide: An Oral Diuretic ,  Lancet 1:1199-1201, 1958.
14.
Pitts, R. P.; Kruck, F.; Lozano, R.; Taylor, D. W.; Heidenreich, O. P. A., and Kessler, R. H.:  Studies on the Mechanism of Diuretic Action of Chlorothiazide ,  J. Pharmacol. & Exper. Therap. 123:89-97, 1958.
15.
Matheson, N. A., and Morgan, T. N.:  Diuretic Action of Chlorothiazide ,  Lancet 1:1195-1199, 1958.
16.
Wilkins, R.W.:  Precautions in the Use of Antihypertensive Drugs Including Chlorothiazide ,  J.A.M.A. 167:801-807, 1958.
17.
Magid, G. J., and Forsham, P. H.:  Clinical Studies on the Diuretic Effect of Chlorothiazide ,  Metabolism 7:589-606, 1958.
18.
Beyer, K. H.:  Nonmercurial Organic Diuretics ,  A.M.A. Arch. Int. Med. 102:1005-1013, 1958.
19.
Dinon, L. R.; Kim, Y. S., and Vander Veer, J. B.:  Clinical Experience with Chlorothiazide (Diuril) with Particular Emphasis on Untoward Responses: A Report of 121 Cases Studied over a 15 Month Period ,  Am. J.M. Sc. 236:533-544, 1958.
20.
DeAlvarez, R. R., and O'Lane, J. M.:  Influence of Chlorothiazide on Water and Electrolyte Excretion in Preeclampsia ,  J.A.M.A. 168: 2226-2234, 1958.
21.
Myerson, R. M.; Stout, R. E., and Forte, A. L.:  Acetazolamide and Chlorothiazide in the Treatment of Ascites Due to Cirrhosis of the Liver ,  New England J. Med. 260:28-30, 1959.Crossref
22.
Schreiner, G. E., and Bloomer, H. A.:  Effect of Chlorothiazide on the Edema of Cirrhosis, Nephrosis, Congestive Heart Failure and Chronic Renal Insufficiency ,  New England J. Med. 257: 1016-1022, 1957.Crossref
23.
Ford, R. V.; Rochelle, J. B., III; Handley, C. A.; Moyer, J. H., and Spurr, C. L.:  Choice of a Diuretic Agent Based on Pharmacological Principles ,  J.A.M.A. 166:129-136, 1958.Crossref
24.
Bayliss, R. I. S.; Marrach, D.; Pirkis, J.; Rees, J. R., and Zilva, J. F.:  Chlorothiazide: An Oral Diuretic ,  Lancet 1:120-124, 1958.Crossref
25.
Slater, J. D. H., and Nabavio, J. D. N.:  Clinical Experience with Chlorothiazide ,  Lancet 1:124-127, 1958.Crossref
26.
Freis, E. D.:  Treatment of Hypertension with Chlorothiazide ,  J.A.M.A. 169:105-108, 1959.Crossref
27.
Corsa, L., Jr.; Olney, J. M., Jr.; Steenburg, R. W.; Ball, M. R., and Moore, F. D.:  The Measurement of Exchangeable Potassium in Man by Isotope Dilution ,  J. Clin. Invest. 29:1280-1294, 1950.Crossref
28.
Deane, N., and Smith, H. W.:  The Distribution of Sodium and Potassium in Man ,  J. Clin. Invest. 31:197-199, 1952.Crossref
29.
James, A. H.; Brooks, L.; Edelman, I. S.; Olney, J. M., and Moore, F. D.:  Body Sodium and Potassium: I. Simultaneous Measurement of Exchangeable Sodium and Potassium in Man by Isotope Dilution ,  Metabolism 3:313-322, 1954.
30.
Edelman, I. S.; James, A. H.; Brooks, L., and Moore, F. D.:  Body Sodium and Potassium: IV. The Normal Total Exchangeable Sodium; Its Measuremen0t and Magnitude ,  Metabolism 3:530-537, 1954.
31.
Dahl, L. K.; Stall, B. G., III, and Cotzias, G. C.:  Metabolic Effects of Marked Sodium Restriction in Hypertensive Patients: Changes in Total Exchangeable Sodium and Potassium ,  J. Clin. Invest. 33:1397-1405, 1954.Crossref
32.
Platt, R.:  Structural and Functional Adaptation in Renal Failure ,  Brit. M.J. 1:1313, 1372-1377, 1952.Crossref
33.
Brooks, R. V.; McSweney, R. R.; Prunty, F. T. G., and Wood, F. J. Y.:  Potassium Deficiency of Renal and Adrenal Origin ,  Am. J. Med. 23:391-406, 1957.Crossref
34.
Bartter, F. C.:  The Role of Aldosterone in Normal Homeostasis and in Certain Disease States ,  Metabolism 5:369-382, 1956.
35.
Earle, D. P.; Sherry, S.; Eichna, L. W., and Conan, N. J.:  Low Potassium Syndrome Due to Defective Renal Tubular Mechanisms for Handling Potassium ,  Am. J. Med. 11:283-301, 1951.Crossref
36.
Schwartz, W. B., and Relman, A.:  Metabolic and Renal Studies in Chronic Potassium Depletion Due to Overuse of Laxatives ,  J. Clin. Invest. 32:258-270, 1953.Crossref
37.
Relman, A. S., and Schwartz, W. B.:  Nephropathy of Potassium Depletion: Clinical and Pathological Entity ,  New England J. Med. 255: 195-203, 1956.Crossref
38.
Stanbury, S. W.:  Some Aspects of Disordered Renal Tubular Function ,  Advances Int. Med. 9:231-282, 1958.
39.
Chasis, H.; Goldring, W.; Breed, E. S.; Schreiner, G. E., and Bolomey, A. A.:  Salt and Protein Restriction: Effects on Blood Pressure and Renal Hemodynamics in Hypertensive Patients ,  J.A.M.A. 142:711-715, 1950.Crossref
40.
Blake, W. D.:  Salt Restriction and the Control of Glomerular Filtration ,  Proc. Am. Soc. Clin. Invest. 35:691-692, 1956.
41.
Anderson, H. M., and Laragh, J. H.:  Renal Excretion of Potassium in Normal and Sodium Depleted Dogs ,  J. Clin. Invest. 37:323-330, 1958.Crossref
42.
Mudge, G. H.:  Potassium Imbalance ,  Bull. New York Acad. Med. 29:846-862, 1953.
43.
Knowles, H. C., Jr.; Levitin, H., and Bridges, A.:  Salt-Losing Nephritis with Fixed Urinary Composition ,  Am. J. Med. 22:158-162, 1957.Crossref
44.
Tapia, F. A.; Dustan, H. P.; Schneckloth, R. A.; Corcoran, A. C., and Page, I. H.:  Enhanced Effectiveness of Ganglion Blocking Agents in Hypertensive Patients During Administration of a Saluretic Agent (Chlorothiazide) ,  Lancet 2:831-833, 1957.Crossref
×